PATENT CLAIM ANALYSIS

Application Number: 16263200
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-07
Patent Classification: ["514", "04400A"]

Abstract:
This disclosure relates to novel huntingtin targets. Novel oligonucleotides for the treatment of Huntington's disease are also provided.

Claim (Index 82):
The RNA duplex of  claim 81 , wherein the sense strand is between 15 and 30 nucleotides in length and comprises a nucleotide sequence which is at least 80% identical to SEQ ID NO: 1056.

Metadata:
- Claim Count in Document: 45.0
- Percentile: 99.0
- Lexical Diversity: 1.05
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15089319', '15697120', '15814350', '15089437', '15419593']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8431243095579292
- 35 USC 102 Novelty (BERT): 0.6398463669693065
- Combined Prediction Score: 0.8227965152990669
- Mean Citation Score: 629.611414
- Max Citation Score: 801.5308
- Similarity Product: 531.6888043005226

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test